Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gabriel Steg

Showing results (891-900 of 962) with videos related to

Pageof 97
Sort By:
The New England Journal of Medicine|November 18, 2014
Twelve or 30 months of dual antiplatelet therapy after drug-eluting stentsLaura Mauri, Dean J Kereiakes, Robert W Yeh, et al.
Journal of the American College of Cardiology|May 15, 2007
Patients with prior myocardial infarction, stroke, or symptomatic peripheral arterial disease in the CHARISMA trialDeepak L Bhatt, Marcus D Flather, Werner Hacke, et al.
European Heart Journal|February 15, 2022
Estimation of recurrent atherosclerotic cardiovascular event risk in patients with established cardiovascular disease: the updated SMART2 algorithmSteven H J Hageman, Ailsa J McKay, Peter Ueda, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|December 13, 2019
Impact of recruitment and retention on all-cause mortality in a large all-comers randomised controlled trial: insights from the GLOBAL LEADERS trialKuniaki Takahashi, Norihiro Kogame, Mariusz Tomaniak, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|September 17, 2020
PRECISE-DAPT score for bleeding risk prediction in patients on dual or single antiplatelet regimens: insights from the GLOBAL LEADERS and GLASSYFelice Gragnano, Dik Heg, Anna Franzone, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|June 29, 2023
Impact of chronic kidney disease and diabetes on clinical outcomes in women undergoing PCIAlessandro Spirito, Dipti Itchhaporia, Samantha Sartori, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|February 4, 2021
Predicting 2-year all-cause mortality after contemporary PCI: Updating the logistic clinical SYNTAX scorePly Chichareon, David van Klaveren, Rodrigo Modolo, et al.
American Heart Journal|September 20, 2005
A global view of atherothrombosis: baseline characteristics in the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trialDeepak L Bhatt, Keith A Fox, Werner Hacke, et al.
JAMA Cardiology|September 21, 2022
Complete Revascularization vs Culprit Lesion-Only Percutaneous Coronary Intervention for Angina-Related Quality of Life in Patients With ST-Segment Elevation Myocardial Infarction: Results From the COMPLETE Randomized Clinical TrialShamir R Mehta, Jia Wang, David A Wood, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|February 2, 2020
The association of body mass index with long-term clinical outcomes after ticagrelor monotherapy following abbreviated dual antiplatelet therapy in patients undergoing percutaneous coronary intervention: a prespecified sub-analysis of the GLOBAL LEADERS TrialMasafumi Ono, Ply Chichareon, Mariusz Tomaniak, et al.
Pageof 97

Showing results (891-900 of 962) with videos related to

Sort By:
Pageof 97
The New England Journal of Medicine|November 18, 2014
Twelve or 30 months of dual antiplatelet therapy after drug-eluting stentsLaura Mauri, Dean J Kereiakes, Robert W Yeh, et al.
Journal of the American College of Cardiology|May 15, 2007
Patients with prior myocardial infarction, stroke, or symptomatic peripheral arterial disease in the CHARISMA trialDeepak L Bhatt, Marcus D Flather, Werner Hacke, et al.
European Heart Journal|February 15, 2022
Estimation of recurrent atherosclerotic cardiovascular event risk in patients with established cardiovascular disease: the updated SMART2 algorithmSteven H J Hageman, Ailsa J McKay, Peter Ueda, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|December 13, 2019
Impact of recruitment and retention on all-cause mortality in a large all-comers randomised controlled trial: insights from the GLOBAL LEADERS trialKuniaki Takahashi, Norihiro Kogame, Mariusz Tomaniak, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|September 17, 2020
PRECISE-DAPT score for bleeding risk prediction in patients on dual or single antiplatelet regimens: insights from the GLOBAL LEADERS and GLASSYFelice Gragnano, Dik Heg, Anna Franzone, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|June 29, 2023
Impact of chronic kidney disease and diabetes on clinical outcomes in women undergoing PCIAlessandro Spirito, Dipti Itchhaporia, Samantha Sartori, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|February 4, 2021
Predicting 2-year all-cause mortality after contemporary PCI: Updating the logistic clinical SYNTAX scorePly Chichareon, David van Klaveren, Rodrigo Modolo, et al.
American Heart Journal|September 20, 2005
A global view of atherothrombosis: baseline characteristics in the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trialDeepak L Bhatt, Keith A Fox, Werner Hacke, et al.
JAMA Cardiology|September 21, 2022
Complete Revascularization vs Culprit Lesion-Only Percutaneous Coronary Intervention for Angina-Related Quality of Life in Patients With ST-Segment Elevation Myocardial Infarction: Results From the COMPLETE Randomized Clinical TrialShamir R Mehta, Jia Wang, David A Wood, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|February 2, 2020
The association of body mass index with long-term clinical outcomes after ticagrelor monotherapy following abbreviated dual antiplatelet therapy in patients undergoing percutaneous coronary intervention: a prespecified sub-analysis of the GLOBAL LEADERS TrialMasafumi Ono, Ply Chichareon, Mariusz Tomaniak, et al.
Pageof 97